Sponsor:
Unity Health Toronto
Code:
NCT01775332
Conditions
Pituitary Neoplasms
Prolactinoma
ACTH-Secreting Pituitary Adenoma
Gigantism
Growth Hormone-Secreting Pituitary Adenoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Educational Intervention
Brief summary:
Conditions
Pituitary Neoplasms
Prolactinoma
ACTH-Secreting Pituitary Adenoma
Gigantism
Growth Hormone-Secreting Pituitary Adenoma
Study ID
NCT01775332
Start date
Feb, 2014
Status verified date
Jul, 2015
Completion date
Dec, 2015
Anticipated
Primary completion date
Dec, 2015
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Educational Intervention
no intervention: No Intervention/Use of Own Resources
Interventions
Educational Intervention
Primary outcome measure
Central contacts
Locations
St. Michael's Hospital
Recruiting
Toronto, Ontario, Canada, M5B1T8
Contacts
Principal Investigator:
Michael Cusimano, MD, PhD
Sponsor
Unity Health Toronto
Last update posted
Jul 31, 2015
Last verified
Jul, 2015
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Unity Health Toronto on 2015-07-31.